Is it Time for a New Paradigm in Calcific Aortic Valve Disease?

JACC: Cardiovascular Imaging

Volumn 2, Issue 8, 2009, Pages 928-930

  Owens, David S ^a   Otto, Catherine M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; REACTIVE OXYGEN METABOLITE; SIMVASTATIN;

AORTA ATHEROSCLEROSIS; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; BLOOD VESSEL CALCIFICATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE PREDISPOSITION; DOPPLER ECHOCARDIOGRAPHY; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HUMAN; IMAGE ANALYSIS; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGE FACTORS; AORTA; AORTIC VALVE; AORTIC VALVE STENOSIS; BLOOD PLATELETS; CALCINOSIS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; ELASTICITY; ENDOTHELIUM, VASCULAR; HEART VALVE DISEASES; HUMANS; NITRIC OXIDE; PLATELET AGGREGATION; PULSATILE FLOW; RISK ASSESSMENT; RISK FACTORS; SCLEROSIS;

EID: 68549130719     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.02.016     Document Type: Editorial

References (7)

1. Stewart B.F., Siscovick D., Lind B.K., et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29 (1997) 630-634
2. Katz R., Wong N.D., Kronmal R., et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 113 (2006) 2113-2119
3. Cowell S.J., Newby D.E., Prescott R.J., et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352 (2005) 2389-2397
4. Rossebø A., Pedersen T., Boman K., et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 359 (2008) 1343-1356
5. Miller J., Chu Y., Brooks R., Richenbacher W., Peña-Silva R., and Heistad D. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol 52 (2008) 843-850
6. Ngo D.T.M., Sverdlov A.L., Willoughby S.R., et al. Determinants of occurrence of aortic sclerosis in an aging population. J Am Coll Cardiol Img 2 (2009) 919-927
7. Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., and Siscovick D.S. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 341 (1999) 142-147